CLINICAL AND EXPERIMENTAL HYPERTENSION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2023-10-19 ms4000001698136241 来自广东省

刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......

182 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2019-12-17 keping2001

审稿速度:6.0
经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎

210 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2022-08-02 麦田捕手

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：高血压临床方向;高血压
经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费

161 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2023-07-11 ms1911033254033917 来自江苏省

什么原因突然升那么高，能保持住吗

160 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2019-05-11 145dece4m12(暂无昵称)

12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？

316 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

什么是correspondingauthor/通讯作者？

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

期刊可以有几个通讯作者/第一作者？

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2017-12-15 四叶1

审稿速度:1.0 | 投稿命中率:50.0
经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。

288 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2017-12-23 四叶1

您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表:
请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?

邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?

316 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2163802, encodeId=2f4621638028a, content=刚接收一篇，还没交版面费，Web of Science一查，影响因子是2.6，其他平台查都是12.3，有没有兄弟知道怎么回事啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Oct 19 20:22:04 CST 2023, time=2023-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=581676, encodeId=6b905816e6fb, content=审稿速度:6.0 经验分享：已经投稿6个月了,一直在审稿, 太慢. 发邮件也不回.着急用的特别谨慎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc2c28843, createdName=keping2001, createdTime=Tue Dec 17 21:09:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236175, encodeId=b79612361e55d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：高血压临床方向;高血压 经验分享：新的一年影响因子2分出头，涨了一点，投了一篇中西医结合治疗高血压的meta分析，感觉写的很简单，初审加外审一共三个月，催过一次，只有一个审稿人，审稿人给的意见很正面，几乎没怎么改。就是审稿很慢，感觉很早意见就回来了只是一直没处理，不需要版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1805555577, createdName=麦田捕手, createdTime=Tue Aug 02 16:37:30 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147422, encodeId=617f214e42247, content=什么原因突然升那么高，能保持住吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=532a1880823, createdName=ms1911033254033917, createdTime=Tue Jul 11 09:12:37 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570753, encodeId=8e545e07535f, content=12月底投的文章，审稿已经4个多月了还是under review状态，是要继续等还是催稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:40:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088829, encodeId=fb8c10888296d, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088830, encodeId=771910888307a, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550049, encodeId=62c7550049e4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：9月23日投稿，10月10日大修，11月15日修回，11月17日小修，11月19日修回，11月26日接受，需要填online author agreement form.在线表格，但是目前还没有收到信息，哪位大神投过，望告知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Fri Dec 15 22:54:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550283, encodeId=78b75502837f, content=您好.接收后多久可以见刊?邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, beContent=邈邈ZH 2017-04-25 11:04:00 发表: 请问.什么时候可以收到online author agreement form?是等编辑发过来再填吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23731987466, createdName=四叶1, createdTime=Sat Dec 23 00:00:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550662, encodeId=31c3550662c9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c181602601, createdName=lihenew, createdTime=Thu Jan 04 21:37:00 CST 2018, time=2018-01-04, status=1, ipAttribution=)]

2018-01-04 lihenew

审稿速度:2.0 | 投稿命中率:50.0
经验分享：初稿到小修大概2个月，小修到录用大概1.5个月，现在已经接收。但是不知道online author agreement form 怎么弄？是编辑发过来还是自己找啊？第一次投稿，没有经验，望在此刊发表过的朋友给个定心丸，谢谢啦！！

330 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务